EDIT - Editas Medicine Inc
IEX Last Trade
3.75
0.040 1.067%
Share volume: 1,135,914
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.71
0.04
1.08%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-03 | 2022-11-02 | 2023-02-22 | 2023-05-05 | 2023-08-02 | 2023-11-03 | 2024-02-28 | 2024-05-08 | |
Total revenue | 6.362 M | 42.000 K | 6.537 M | 9.851 M | 2.887 M | 5.336 M | 60.049 M | 1.135 M | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 6.362 M | 42.000 K | 6.537 M | 9.851 M | 2.887 M | 5.336 M | 60.049 M | 1.135 M | |
-99.34% | 15,464.29% | 50.70% | -70.69% | 84.83% | 1,025.36% | -98.11% | |||
Operating expenses | 60.596 M | 57.562 M | 69.983 M | 60.812 M | 46.981 M | 55.499 M | 84.012 M | 68.126 M | |
Selling general and admin | 16.937 M | 16.236 M | 17.986 M | 23.008 M | 17.202 M | 14.987 M | 14.456 M | 19.339 M | |
Research and development | 43.659 M | 41.326 M | 51.997 M | 37.804 M | 29.779 M | 40.512 M | 69.556 M | 48.787 M | |
Total expenses | 60.596 M | 57.562 M | 69.983 M | 60.812 M | 46.981 M | 55.499 M | 84.012 M | 68.126 M | |
-5.01% | 21.58% | -13.10% | -22.74% | 18.13% | 51.38% | -18.91% | |||
Operating income | -54.234 M | -57.520 M | -63.446 M | -50.961 M | -44.094 M | -50.163 M | -23.963 M | -66.991 M | |
Ebit | -54.234 M | -57.520 M | -63.446 M | -50.961 M | -44.094 M | -50.163 M | -23.963 M | -66.991 M | |
Pretax income | -53.453 M | -55.726 M | -60.738 M | -49.036 M | -40.290 M | -45.019 M | -18.874 M | -61.950 M | |
4.25% | 8.99% | -19.27% | -17.84% | 11.74% | -58.08% | 228.23% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -53.453 M | -55.726 M | -60.738 M | -49.036 M | -40.290 M | -45.019 M | -18.874 M | -61.950 M | |
-4.25% | -8.99% | 19.27% | 17.84% | -11.74% | 58.08% | -228.23% | |||
Net income | -53.453 M | -55.726 M | -60.738 M | -49.036 M | -40.290 M | -45.019 M | -18.874 M | -61.950 M | |
-4.25% | -8.99% | 19.27% | 17.84% | -11.74% | 58.08% | -228.23% |